Demo Data from EDBT 2026 / reviewers in the wild / expert
Pau Erola
dblp:92/11049 · also Pau Erola Cañellas
· DBLP profile ↗
3ranked-venue papers
1as first author
2since 2021 · last 2021
0000-0003-4440-0068ORCID · corroborated
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 3 · 1 first-author · 2 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
2 papers |
Bioinformatics and computational biology · 61% Medical and health informatics · 19% Computational social science and digital humanities · 19% |
Topics — the 6 heaviest of 6, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › knowledge representation in biology
biomedical knowledge graph |
0.5 | 1 | 2021 | EpiGraphDB: a database and data mining platform for health data science · Bioinform. 2021 |
Computational social science and digital humanities
causal inference |
0.5 | 1 | 2021 | EpiGraphDB: a database and data mining platform for health data science · Bioinform. 2021 |
Medical and health informatics
epidemiology |
0.5 | 1 | 2021 | EpiGraphDB: a database and data mining platform for health data science · Bioinform. 2021 |
Bioinformatics and computational biology › statistical genetics › genetic study design
mendelian randomization |
0.5 | 1 | 2021 | EpiGraphDB: a database and data mining platform for health data science · Bioinform. 2021 |
Bioinformatics and computational biology
gene expression analysis |
0.4 | 1 | 2020 | Model-based clustering of multi-tissue gene expression data · Bioinform. 2020 |
Bioinformatics and computational biology › drug discovery › target identification
drug target identification |
0.1 | 1 | 2021 | EpiGraphDB: a database and data mining platform for health data science · Bioinform. 2021 |
Methods — techniques the papers use, named apart from their topics
graph database · 0.5data mining · 0.5data integration · 0.5bayesian model-based clustering · 0.4
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2021 | Erratum to: EpiGraphDB: a database and data mining platform for health data scienceabstractBioinformatics (2020) doi: 10.1093/bioinformatics/btaa961 Upon the original publication of this article, there was an error in the source code syntax under sub-section “2.2 Integration of epidemiological evidence” in the “Materials and methods” section. The source code syntax should read: “(e.g. (Gwas {trait: ‘Body mass index’})-[MR {beta, se, pval}]->(Gwas {trait: ‘Coronary heart disease’}))” instead of “ (e.g. [Gwas (trait: ‘Body mass index’)]-[MR {beta, se, pval}]->(Gwas {trait: ‘Coronary heart disease’})))”. This error has now been corrected. The Publisher apologizes for the error. Yi Liu 0058, Benjamin L. Elsworth, Pau Erola, Valeriia Haberland, Gibran Hemani, Matt Lyon, Jie Zheng 0006, Oliver Lloyd, Marina Vabistsevits, Tom R. Gaunt |
Bioinform. | 3 |
| 2021 | EpiGraphDB: a database and data mining platform for health data scienceabstractMOTIVATION: The wealth of data resources on human phenotypes, risk factors, molecular traits and therapeutic interventions presents new opportunities for population health sciences. These opportunities are paralleled by a growing need for data integration, curation and mining to increase research efficiency, reduce mis-inference and ensure reproducible research. RESULTS: We developed EpiGraphDB (https://epigraphdb.org/), a graph database containing an array of different biomedical and epidemiological relationships and an analytical platform to support their use in human population health data science. In addition, we present three case studies that illustrate the value of this platform. The first uses EpiGraphDB to evaluate potential pleiotropic relationships, addressing mis-inference in systematic causal analysis. In the second case study, we illustrate how protein-protein interaction data offer opportunities to identify new drug targets. The final case study integrates causal inference using Mendelian randomization with relationships mined from the biomedical literature to 'triangulate' evidence from different sources. AVAILABILITY AND IMPLEMENTATION: The EpiGraphDB platform is openly available at https://epigraphdb.org. Code for replicating case study results is available at https://github.com/MRCIEU/epigraphdb as Jupyter notebooks using the API, and https://mrcieu.github.io/epigraphdb-r using the R package. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Yi Liu 0058, Benjamin L. Elsworth, Pau Erola, Valeriia Haberland, Gibran Hemani, Matt Lyon, Jie Zheng 0006, Oliver Lloyd, Marina Vabistsevits, Tom R. Gaunt |
Bioinform. | 3 |
| 2020 | Model-based clustering of multi-tissue gene expression dataabstractMOTIVATION: Recently, it has become feasible to generate large-scale, multi-tissue gene expression data, where expression profiles are obtained from multiple tissues or organs sampled from dozens to hundreds of individuals. When traditional clustering methods are applied to this type of data, important information is lost, because they either require all tissues to be analyzed independently, ignoring dependencies and similarities between tissues, or to merge tissues in a single, monolithic dataset, ignoring individual characteristics of tissues. RESULTS: We developed a Bayesian model-based multi-tissue clustering algorithm, revamp, which can incorporate prior information on physiological tissue similarity, and which results in a set of clusters, each consisting of a core set of genes conserved across tissues as well as differential sets of genes specific to one or more subsets of tissues. Using data from seven vascular and metabolic tissues from over 100 individuals in the STockholm Atherosclerosis Gene Expression (STAGE) study, we demonstrate that multi-tissue clusters inferred by revamp are more enriched for tissue-dependent protein-protein interactions compared to alternative approaches. We further demonstrate that revamp results in easily interpretable multi-tissue gene expression associations to key coronary artery disease processes and clinical phenotypes in the STAGE individuals. AVAILABILITY AND IMPLEMENTATION: Revamp is implemented in the Lemon-Tree software, available at https://github.com/eb00/lemon-tree. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Pau Erola, Johan Björkegren, Tom Michoel |
Bioinform. | 1 |